[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Horsti, 2002 - Google Patents

Has the Quick or the Owren prothrombin time method the advantage in harmonization for the International Normalized Ratio system?

Horsti, 2002

Document ID
3995370120538681638
Author
Horsti J
Publication year
Publication venue
Blood coagulation & fibrinolysis

External Links

Snippet

Prothrombin time (PT) is the most commonly used coagulation test in health care. We sought here to compare two major PT methods (Quick and Owren) for harmonization of International Normalized Ratio (INR) results. We measured PT with an ACL 7000 analyser. We used …
Continue reading at journals.lww.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology

Similar Documents

Publication Publication Date Title
Bonar et al. Overview of hemostasis and thrombosis and contribution of laboratory testing to diagnosis and management of hemostasis and thrombosis disorders
Takemoto et al. Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance
Stangier et al. Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran
Lippi et al. Short-term venous stasis influences routine coagulation testing
Toffaletti et al. Use of earlier-reported rotational thromboelastometry parameters to evaluate clotting status, fibrinogen, and platelet activities in postpartum hemorrhage compared to surgery and intensive care patients
Duncan et al. One-stage factor VIII assays
Exner et al. Testing for new oral anticoagulants with LA-resistant Russells viper venom reagents. An in vitro study
Favaloro et al. Standardization of the INR: how good is your laboratory's INR and can it be improved?
Rodgers et al. Chromogenic factor VIII assays for improved diagnosis of hemophilia A
Van den Besselar A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin
Gouin-Thibault et al. Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study
van den Besselaar Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation
Ignjatovic Prothrombin time/international normalized ratio
Horsti Has the Quick or the Owren prothrombin time method the advantage in harmonization for the International Normalized Ratio system?
Suzuki et al. Performance evaluation of Revohem™ FVIII chromogenic and Revohem™ FIX chromogenic in the CS‐5100 autoanalyser
van den Besselaar et al. Defining a metrologically traceable and sustainable calibration hierarchy of international normalized ratio for monitoring of vitamin K antagonist treatment in accordance with International Organization for Standardization (ISO) 17511: 2020 standard: communication from the International Federation of Clinical Chemistry and Laboratory Medicine–SSC/ISTH working group on prothrombin time/international normalized ratio standardization
Adcock et al. Enhanced standardization of the International Normalized Ratio through the use of plasma calibrants: a concise review
Smock et al. What have we learned from coagulation laboratory participation in external quality programs?
Horsti Agreement of Owren and Quick prothrombin times: effects of citrate and calcium concentrations and international sensitivity index correction
Horsti Comparison of Quick and Owren prothrombin time with regard to the harmonisation of the International Normalised Ratio (INR) system
Tripodi et al. How to evaluate the influence of blood collection systems on the international sensitivity index. Protocol applied to two new evacuated tubes and eight coagulometer/thromboplastin combinations
Kim et al. The rivaroxaban-adjusted normalized ratio: use of the prothrombin time to monitor the therapeutic effect of rivaroxaban
Tripodi et al. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of
Awad et al. Influence of storage time and temperature on international normalized ratio (INR) levels and plasma activities of vitamin K dependent clotting factors
Schaden et al. Determination of enoxaparin with rotational thrombelastometry using the prothrombinase-induced clotting time reagent